• Journal of Preventive Medicine and Public Health
• /
• 제41권1호
• /
• pp.39-44
• /
• 2008

Objectives : This study was conducted to investigate the associations of non alcoholic fatty liver with metabolic syndrome and the serum carotenoids. Methods : This study was conducted in a general hospital in South Korea from November, 2004 to August, 2005. The study subjects were 350 sampled persons who were aged from 40 years and older (males : 180, females : 170). They were grouped into the normal, mild and severe groups according to fat accumulation in their livers, as determined by ultrasonography. We analyzed the association between non alcoholic fatty liver and metabolic syndrome by multiple logistic regression analysis and we analyzed the association between non alcoholic fatty liver and the serum carotenoids by a general linear model(ANCOVA). Results : After adjustment for the effect of potential covariates, the prevalence of metabolic syndrome was associated with fat accumulation in the liver (p trend <0.001). If the odds ratio of normal group is 1.00, then that of the mild group is 2.80 (95% C.I=1.17-6.71) and that of the severe group is 7.29 (95% C.I=2.76-19.30). The prevalence of metabolic alterations fitting the criteria of metabolic syndrome, according to the class of fat accumulation in the liver, was significantly increased, except for criteria of high blood pressure, a large waist circumference and low HDL (high density lipoprotein) cholesterol level (p trend <0.001). The level of serum ${\beta}$-carotene was decreased according to the class of fat accumulation in the liver (p trend=0.036), but the levels of serum ${\alpha}$-carotene, lycopene, ${\beta}$-cryptoxanthin and lutein were not decreased. Conclusions : This study shows that non alcoholic fatty liver was associated with metabolic syndrome and with the serum ${\beta}$-carotene level.

• Asian-Australasian Journal of Animal Sciences
• /
• 제16권12호
• /
• pp.1732-1737
• /
• 2003

An experiment was conducted to investigate the effect of feeding transgenic cottonseed (Bt.) vis-a-vis non-transgenic (non-Bt.) cottonseed on blood biochemical constituents in lactating Murrah buffaloes. Twenty Murrah buffaloes in mid-lactation were divided into 2 groups of 10 each. Animals of group I were fed with 39.5% non-transgenic cottonseed in concentrate mixture while the same percentage of transgenic (Bt.) cottonseed was included in the concentrate mixture fed to the animals of group II. Animals of both groups were fed with concentrate mixture to support their milk production requirements. Each buffalo was also offered 20 kg mixed green fodder (oats and berseem) and wheat straw ad libitum. The experimental feeding trial lasted for 35 days. There was no significant difference in the dry matter intake between the two groups of buffaloes. All the buffaloes gained body weight, however, the differences were non significant. Total erythrocyte count, hemoglobin content and packed cell volume were $9.27{\pm}0.70${\times}10^6/{\mu}l$, $13.01{\pm}0.60gdl$ and $34.87{\pm}1.47%$, respectively in group I with the corresponding figures of $8.88{\pm}0.33$, $12.99{\pm}0.52$ and $31.08{\pm}1.52$ in group II. The values of total erythrocyte count, haemoglobin content and packed cell volume did not differ significantly between the two groups of buffaloes. The concentration of plasma glucose, serum total proteins, albumin, globulin, triglycerides and high density lipoprotein were non significantly higher in buffaloes fed non-transgenic cottonseed than in buffaloes fed transgenic cottonseed. The cholesterol concentration was significantly (p<0.01) higher in buffaloes of group I ($136.84{\pm}8.40mg/dl$) than in buffaloes of group II ($105.20{\pm}1.85mg/dl$). The serum alkaline phosphotase, glutamic-oxaloacetate transaminase and glutamic-pyruate transaminase activities did not differ significantly between two groups of buffaloes. However, serum glutamic-pyruate transaminase activity was considerably high in buffaloes fed nontransgenic cottonseed as compared to buffaloes fed transgenic cottonseed. Bt. proteins in serum samples of animals of group II were not detected after 35 days of feeding trial. It was concluded that transgenic cottonseed and non-transgenic cottonseed have similar nutritional value without any adverse effects on health status of buffaloes as assessed from haematobiochemical constituents.

• Journal of Ginseng Research
• /
• 제40권2호
• /
• pp.160-168
• /
• 2016

Background: Ginseng (Panax ginseng Meyer) is a well-characterized medicinal herb listed in the classic oriental herbal dictionary as "Shin-nong-bon-cho-kyung." Ginseng has diverse pharmacologic and therapeutic properties. Black ginseng (BG, Ginseng Radix nigra) is produced by repeatedly steaming fresh ginseng nine times. Studies of BG have shown that prolonged heat treatment enhances the antioxidant activity with increased radical scavenging activity. Several recent studies have showed the effects of BG on increased lipid profiles in mice. In this study report the effects of water and ethanol extracts of BG on hypercholesterolemia in rats. To our knowledge, this is the first time such an effect has been reported. Methods: Experiments were conducted on male Sprague Dawley rats fed with a high-cholesterol diet supplemented with the water and ethanol extracts of BG (200 mg/kg). Their blood cholesterol levels, serum white blood cell levels, and cholesterol-metabolizing marker genes messenger RNA (mRNA) expression were determined. Liver and adipose tissues were histologically analyzed. Results: We found that BG extracts efficiently reduced the total serum cholesterol levels, low-density lipoprotein (LDL) levels with increased food efficiency ratio and increased number of neutrophil cells. It also attenuated the key genes responsible for lipogenesis, that is, acetyl-coenzyme A (CoA) acetyltransferase 2, 3-hydroxy-3-methyl-glutaryl-CoA reductase, and sterol regulatory element-binding protein 2, at the mRNA level inside liver cells. Furthermore, the BG extract also reduced the accumulation of fat in adipose tissues, and inhibited the neutral fat content in liver cells stained with hematoxylin and eosin and oil red O. Conclusion: Administration of BG extracts to Sprague Dawley rats fed with high-cholesterol diet ameliorated hypercholesterolemia, which was mediated via modulation of cholesterol-metabolizing marker genes. This data throw a light on BG's cardioprotective effects.

• Clinical and Experimental Pediatrics
• /
• 제51권12호
• /
• pp.1310-1314
• /
• 2008

목 적: 군포시 저소득층 소아들의 건강상태를 알아보고 저소득층 소아에서 비만도, 고지혈증, 고혈압, 높은 공복 혈당의 유병률을 알아보고자 본 연구를 시행하였다. 방 법: 2007년 10월부터 2008년 3월까지 원광대 산본병원에서 기초생활수급을 받는 저소득층 가정의 소아 341명을 대상으로 키, 몸무게, 혈압 등 신체계측과 콜레스테롤, 중성지방, HDL-콜레스테롤, 공복혈당, 혈색소, 간기능, 전해질 검사 등을 시행하였다. 결 과: 전체 수검자는 341명으로 남아 174명 여아 167명이였고 평균연령은 여아군이 $9.8{\pm}2.0$세, 남아군이 $9.8{\pm}1.9$세 였으며 두군 모두 연령 범위는 6-13세였다. 체질량지수가 성별 연령별 95백분위수 이상을 비만으로 정하였을 때 비만아는 7.0%였고 고지혈증은 16.7%, 고혈압은 8.2%, 높은 공복혈당을 보인 소아는 0.3%였다. 특히 비만아중 고혈압의 빈도가 25%로 높았다. 결 론: 경제적 수준이 낮은 가정의 소아들에서 비만, 고지혈증, 고혈압의 빈도가 조금 높았으며 공복혈당의 증가는 높지 않았다. 특히 비만아에서의 고혈압 유병율이 높았으며 이는 낮은 경제적 수준이 고혈압의 빈도 증가와 관련이 있다고 하겠다.

• 한국식품과학회지
• /
• 제43권3호
• /
• pp.375-380
• /
• 2011

DSG에 몰로키아 분말을 첨가하여 발효시킨 발효물이 콜레스테롤 개선효과를 가지는지 in vitro 및 in vivo에서 살펴보았다. B. subtilis NUC1균주로 발효한 탈지대두 grits 발효물인 FD와 탈지 대두 grit에 몰로키아를 5, 10%로 각각 첨가하여 발효한 FDC군의 콜레스테롤 흡착능을 살펴본 결과, 모든 군에서 70% 이상의 흡착능을 보였다. HepG2 세포를 이용한 apo-AI, apo-CIII의 분비능 측정에서는 FD군에 비해 몰로키아를 첨가한 FDC군에서 더 우수한 개선효과를 보였다. 한편 FDC가 고지방식이를 급여한 흰쥐의체내 콜레스테롤 개선에 미치는 영향을 살펴보고자, 기본식이군(Con), 고지방식이군(HF) 그리고 고지방식이와 FD첨가군(HFFD), 고지방식이와 FDC 첨가군(HF-FDC)으로 나누어 4주간 사육하였다. 그 결과, 혈장 내 총콜레스테롤 및 LDL-콜레스테롤 함량, 그리고 간 조직 내의 총콜레스테롤 및 중성지질 함량은 HF군에서 증가하였다가 HF-FDC 첨가군에서 유의적으로 감소하였고, 분변 내의 콜레스테롤 및 중성지질 배설량은 FDC 투여로 인해서 HF군에 비해 증가하였다. 또한 간내 HMG-CoA reductase 활성은 HF군에서 증가되었다가, HF-FDC첨가군에서 유의성 있게 감소되었다. 따라서 FDC는 콜레스테롤 흡착 및 조절능을 가지며, 그리고 혈중 콜레스테롤 함량, 조직 내의 지질 및 콜레스테롤 축적을 감소시켜 체내 콜레스테롤 개선에 효과적인 것으로 생각된다.

• 한국식품영양학회지
• /
• 제23권3호
• /
• pp.311-317
• /
• 2010

본 연구는 추출물 형태에 따른 파프리카 첨가 식이가 고콜레스테롤 식이 흰쥐의 혈청 지질과 $\alpha$-tocopherol 농도에 미치는 영향을 알아보기 위해 Sprague-Dawley 수컷 25마리를 대조군(NC), 고콜레스테롤군(HC), 고콜레스테롤+동결건조 파프리카 분말 섭취군(HC-FDP), 고콜레스테롤+파프리카 물 추출물 섭취군(HC-WEP), 고콜레스테롤+파프리카 에탄올 추출물 섭취군(HC-EEP)으로 나누어 실험 식이를 6주간 공급하였다. 6주 후 HC군과 파프리카 급여군에서 체중 증가는 각각 85.2%와 65.5~68.88%로 HC군에서 체중이 유의적으로 증가하였다. 그리고 내장지방 무게는 HC군보다 파프리카 급여군에서 감소하였으며, 파프리카 급여군의 중성지질, 총 콜레스테롤, LDL-콜레스테롤과 atherogenic index 역시 HC군보다 유의적으로 감소하였다(p<0.05). 그리고 파프리카 급여군들 중에서는 HC-EEP 군이 혈청지질농도 감소 효과가 가장 큰 것으로 나타났다. 혈청 $\alpha$-tocopherol 농도는 HC-EEP에서 $30.5{\pm}0.6\;{\mu}mol/{\ell}$로 가장 높았고, 그 다음으로는 HC-WEP($30.0{\pm}0.8\;{\mu}mol/{\ell}$)>HC-FDP($29.1{\pm}0.5\;{\mu}mol/{\ell}$)>HC($27.7{\pm}0.3\;{\mu}mol/{\ell}$)이었다. 이는 고콜레스테롤 식이에 의한 산화적 스트레스를 감소시키기 위하여 혈청 $\alpha$-tocopherol이 소모되는 것을 파프리카 급여로 절약하는 효과를 나타낸 것으로 사료된다. 따라서 본 연구를 통해 파프리카는 혈중 지질 농도 저하 효과를 보였고, $\alpha$-tocopherol 절약 작용을 통해 체내 항산화제로서 활용 가능성을 확인할 수 있었다.

• 한국가금학회지
• /
• 제39권3호
• /
• pp.215-222
• /
• 2012

본 시험은 산란계에 뽕잎 분말의 급여량(0, 1, 2 및 5%)과 급여 기간에 따라 사육한 산란계의 계란 품질, 혈액 생화화적 분석 및 혈액학적 지표 분석를 조사하였다. 실험구는 뽕잎 분말을 첨가 급여하지 않은 처리구를 대조구, 뽕잎 분말 1% 급여구는 T1, 뽕잎 분말 2% 급여구는 T2 그리고 뽕잎 분말 5% 급여구를 T3 등 4개 처리구로 나누어 실시하였다. 산란계의 산란율과 계란의 난황, 난각 무게는 뽕잎 분말의 급여량과 급여 기간에 의한 유의적인 변화는 없었다. 그러나 난백 무게는 뽕잎 분말의 급여량과 급여 기간이 지남에 따라 감소하였다(P<0.05). 그리고 난백 높이, 난황 색, 난각 두께 및 난각 강도는 뽕잎 분말의 급여에 의한 차이는 없었다. 산란계의 혈액 콜레스테롤 성상 중 HDL-cholesterol은 뽕잎 급여량이 많고 급여기간이 길어질수록 증가하였고, 총콜레스테롤과 triglyceride는 낮아지는 결과였으며(P<0.05), 뽕잎분말을 5% 급여할 경우 유의한 변화를 보였다. 또한, 혈액 내 WBC 함량이 뽕잎 분말 급여구에서 높아지는 결과이었다. 결론적으로 뽕잎 분말 5%를 급여하면 총콜레스테롤과 triglyceride는 감소하고, HDL-cholesterol, glucose 및 WBC 함량이 증가되어 혈액 성상을 개선할 가능성이 있는 것으로 판단된다.

• 한국임상약학회지
• /
• 제8권2호
• /
• pp.107-112
• /
• 1998

Lovastatin is a lipid lowering agent for the treatment of hypercholesterolemia and belongs to a new class of pharmacologic compounds called the 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors. By competitively inhibiting HMG CoA reductase, lovastatin disrupts the biosynthesis of cholesterol in hepatic and peripheral cells and increases the synthesis of high-density-lipoprotein HDL) receptors. Following oral administration, the lactone ring of lovastatin is hydrolysed to the active inhibitor of HMG CoA reductase, lovastatin acid. Lovastatin is known to have poor oral absorption and wide individual variation. In this study, bioequivalence test of two lovastatin formulations, the test drug ($Lovaload^{TM}$, Chong Kun Dang Pharmaceutical Co.) and the reference drug ($Mevacor^{TM}$, Chung Wae Pharmaceutical Co.) were conducted according to the guidelines of Korea Food and Drug Administration (KFDA). A total of 18 healthy male volunteers, $31.90\pm3.60$ years old and $72.17\;7.88$ kg of body weight in average, were evaluated in a randomized crossover manner with a 2-week washout period. Concentrations of lovastatin acid in plasma were measured upto 12 hours following a single oral administration of eight tablets (20 mg of lovastatin per tablet) by high-performance liquid chromatography with UV detection at 238 nm. The area under the concentration-vs-time curve from 0 to 12 hours $(AUC_{0-12h})$ was calculated by the trapezoidal summation method. The statistical analysis showed that there are no significant differences in $AUC_{0-12h),\;C_{max}\;and\;T_{max}$ between the two formulations ($6.72\%,\;1.52\%,\;and\;0.88\$, respectively). The least significant differences between the formulations at $\alpha$=0.05 were less than $20\%\;(11.65\%,\;19.73\%,\;and\;14.81\%\;for\;AUC_{0-12h},\;C_{max}\;and\;T_{max}$, respectively). The $90\%$ confidence intervals for these parameters were also within $\pm20\%\;(-1.50{\leq}{\delta}{\leq}15.00$, $-12.50{\leq}{\delta}{\leq}15.50,\;and\;-9.64{\leq}{\delta]{\leq}11.40{\leq}\;for\;\;AUC_{0-12h}$ ,$C_{max}\;and\;T_{max}$, respectively). In conclusion, the new generic product $Lovaload^{TM}$ was proven to be bioequivalent with the reference drug.

• 대한임상검사과학회지
• /
• 제38권2호
• /
• pp.117-124
• /
• 2006

The analytical measurement range (AMR) is the range of analyte values that a method can directly measure on a specimen without any dilution, concentration, or other pretreatment not part of the usual assay process. The linearity of the AMR is its ability to obtain test results which are directly proportional to the concentration of analyte in the sample from the upper and lower limit of the AMR. The AMR validation is the process of confirming that the assay system will correctly recover the concentration or activity of the analyte over the AMR. The test specimen must have analyte values which, at a minimum, are near the low, midpoint, and high values of the AMR. The AMR must be revalidated at least every six months, at changes in major system components, and when a complete change in reagents for a procesure is introduced; unless the laboratory can demonstrate that changing the reagent lot number does not affect the range used to report patient test results. The AMR linearity was total protein (0-16.6), albumin (0-8.1), total bilirubin (0-18.1), alkaline phosphatase (0-1244.3), aspartate aminotransferase (0-1527.9), alanine aminotransferase (0-1107.9), gamma glutamyl transpeptidase (0-1527.7), creatine kinase (0-1666.6), lactate dehydrogenase (0-1342), high density lipoprotein cholesterol (0.3-154.3), sodium (35.4-309), creatinine (0-19.2), blood urea nitrogen (0.5-206.2), uric acid (0-23.9), total cholesterol (-0.3-510), triglycerides (0.7-539.6), glucose (0-672.7), amylase (0-1595.3), calcium (0-23.9), inorganic phosphorus (0.03-17.0), potassium (0.1-116.5), chloride (3.3-278.7). We are sure that materials for the AMR affect the evaluation of the upper limit of the AMR in the process system.

• Journal of Nutrition and Health
• /
• 제46권2호
• /
• pp.156-165
• /
• 2013

This study examined how achievement of session goals contributes to outcomes of subjects after participation in a 12-week lifestyle intervention program in men with metabolic syndrome (MetS). Thirty office workers with MetS, aged $47.2{\pm}6.6$ years, participated in this study, from March to July, 2011. The intervention program included face-to-face counseling five times during the 12-week period. Counselors and subjects designed session goals for each round. The average of the goal achievement rate was calculated based on compliance for each round. The subjects were divided into three groups according to their tertiles of achievement rate: Low-compliance group (LC, < 59%), medium-compliance group (MC, 59-70%), and high-compliance group (HC, > 70%). Anthropometry, biochemical index, and nutrient intake were examined at baseline and at the end of the 12-week intervention program. After the intervention, diastolic blood pressure (DBP) showed a significant decrease in the LC group, and waist circumference (WC) showed a significant decrease in the MC group. Systolic blood pressure (SBP), DBP, and low-density lipoprotein cholesterol (LDL) showed a significant decrease in the HI group. Changes in SBP and DBP were significantly lower in the HC group than in the MC group (p < 0.05, p < 0.01). Changes in LDL were significantly lower in the HC group than in the MC group (p < 0.05). Results for intake of total energy, protein, fat, and sodium, as well as rates of carbohydrate and fat intake, showed a significant decrease in all participants (p < 0.05). The change in fiber was significantly higher in the HC group than in the MC group (p < 0.05). The change of fruit serving size showed a significant increase in the HC group (p < 0.01). The number of risk factors for MetS showed a significant decrease in the LC and HC groups (p < 0.05), however, no significant mean differences were observed among the three groups. In conclusion, participation in this intervention program resulted in positive effects on risk factors for MetS, nutrient intake, and dietary habits, especially in the High-compliance group.